Skip to main content
HairCited

米诺地尔(Minoxidil) 用于 女性型脱发

A

基于67项研究(4项荟萃分析、11项RCT),共28,815名参与者。53/67项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None 效果: None None

研究人群: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss 效果: None None

研究人群: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo 效果: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo 效果: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo 效果: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo 效果: None None

Key Statistics

111

研究数量

37800

受试者

Positive

A

等级

Referenced Papers

Australian prescriber 2025 2 次引用
Annals of dermatology 2025
SAGE open medical … 2024 3 次引用
Drugs 2023 221 次引用
Anais brasileiros de … 2023 29 次引用
Journal of cosmetic … 2023 3 次引用
The Journal of … 2022 170 次引用
Faculty reviews 2022 44 次引用
Journal of cosmetic … 2022 7 次引用
Journal of the … 2021 42 次引用
American journal of … 2020 127 次引用
International journal of … 2020 58 次引用
Indian dermatology online … 2020 31 次引用
Actas dermo-sifiliograficas 2019 5 次引用
International journal of … 2018 129 次引用
Australian journal of … 2018 8 次引用
JAMA dermatology 2017 121 次引用
The Cochrane database … 2016 18 次引用
The Medical clinics … 2015 66 次引用
World journal of … 2015 62 次引用
Seminars in cutaneous … 2015 20 次引用
Clinical obstetrics and … 2015 9 次引用
Current problems in … 2015 8 次引用
Skin therapy letter 2014 29 次引用
Journal of drugs … 2014 26 次引用
Dermatologic clinics 2013 78 次引用
International journal of … 2013 61 次引用
Indian journal of … 2013 16 次引用
International journal of … 2013
The Cochrane database … 2012 15 次引用
Skinmed 2012 5 次引用
The Australasian journal … 2011 44 次引用
Seminars in cutaneous … 2009 4 次引用
American family physician 2009
Journal of the … 2008 290 次引用
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 次引用
The British journal … 2005 205 次引用
The journal of … 2003 102 次引用
Clinical and experimental … 2002 61 次引用
Therapeutische Umschau. Revue … 2002 4 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

topical:
2-5% solution, twice daily

上限: 5% topical solution

研究中使用的剂量

剂量 持续时间 效果 N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

最佳服用时间: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

已报告的副作用

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

已知相互作用

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

可耐受最高摄入量: 5% topical solution

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 米诺地尔(Minoxidil) help with 女性型脱发?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that 米诺地尔(Minoxidil) may support 女性型脱发 management. Our evidence grade is A (Strong Evidence).
How much 米诺地尔(Minoxidil) should I take for 女性型脱发?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 米诺地尔(Minoxidil)?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 米诺地尔(Minoxidil) and 女性型脱发?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。